Live Quote · NASDAQNAGEHealthcare· Biotechnology

Niagen Bioscience Inc

$3.43 3.00%(+$0.10)
TickerSpark Score
78/100
Solid
80
Valuation
95
Profitability
100
Growth
84
Health
30
Momentum

Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a NAGE research report →

52-Week Range3% of range
Low
$3.18
Current
$3.43
High
$12.65
Company Overviewwww.niagenbioscience.com

About the company

Niagen Bioscience Inc operates as a biotechnology enterprise with a core focus on promoting healthy aging. This company is also renowned for its pioneering research into nicotinamide adenine dinucleotide.

CEO
Robert N. Fried
IPO
2015
Employees
104
HQ
Los Angeles, CA, US

Price Chart

-72.73% · this period
$12.71$7.95$3.19Jul 02Dec 31Jul 02
Valuation
Market Cap
$273.18M
P/E
14.64
P/S
2.09
P/B
3.33
EV/EBITDA
9.78
Div Yield
0.00%
Profitability
Gross Margin
64.28%
Op Margin
8.51%
Net Margin
14.29%
ROE
25.38%
ROIC
11.35%
Growth & Income
Revenue
$129.42M · 29.95%
Net Income
$17.38M · 103.30%
EPS
$0.22 · 120.00%
Op Income
$14.30M
FCF YoY
10.04%
Performance & Tape
52W High
$12.65
52W Low
$3.18
50D MA
$3.87
200D MA
$5.70
Beta
2.06
Avg Volume
828.66K

Get TickerSpark's AI analysis on NAGE

Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.

Get Pro Access →

Already have an account? Log in

Form 4 · Filings

Recent insider transactions

Who's buying, who's selling, and how much.

DateInsiderTypeShares
Jun 24, 26YU Wing Tak Wendyother31,746
Jun 24, 26Ng Wang Yu Garyother31,746
Jun 24, 26Cohen Annother31,746
Jun 24, 26Patrick Kristinother31,746
Jun 24, 26Shahbazi Hamedother31,746
Jun 24, 26Rubin Steven Dother31,746
Jun 24, 26Jaksch Frank L Jrother31,746
Apr 24, 26Fried Robert Nother20,000
Apr 24, 26Fried Robert Nother20,000
Feb 19, 26Lopez Carlos Luisother41,420
Coverage · NAGE

Our NAGE coverage

Recent articles, reports, and earnings notes.

On-Demand Research

No research on NAGE yet

For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.

Generate NAGE report →
Internal Compare

Similar companies

Peers in the same neighborhood.